Goldman Sachs’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Goldman Sachs’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-51,831	Closed	-$1.26M	–	6665
2017 Q4	$1.26M	Buy	51,831 +17,309	+50%	+$333K	﹤0.01%	4154
2017 Q3	$637K	Buy	34,522 +5,167	+18%	+$89.5K	﹤0.01%	4924
2017 Q2	$486K	Sell	29,355 -1,325	-4%	-$18.4K	﹤0.01%	5123
2017 Q1	$423K	Buy	+30,680	New	+$493K	﹤0.01%	5176

Goldman Sachs's ENTL Position: Q1 2018 in Review

Goldman Sachs sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 51,831 shares — an estimated $1.26M sold.

Goldman Sachs first reported a position in ENTL in Q1 2017 and held it in 4 quarters. The position peaked at $1.26M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Goldman Sachs reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Goldman Sachs sold 51,831 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.26M.
Goldman Sachs first reported a position in Entellus Medical, Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Goldman Sachs's Entellus Medical, Inc. Common Stock position peaked at $1.26M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Goldman Sachs's 13F filing for Q1 2018, filed 15 May 2018.